Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000713787 | SCV000844419 | uncertain significance | not provided | 2018-03-19 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001112244 | SCV001269886 | uncertain significance | Maturity-onset diabetes of the young type 3 | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Ce |
RCV000713787 | SCV001502151 | uncertain significance | not provided | 2021-02-01 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002463735 | SCV002605163 | uncertain significance | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Mutations in HNF1A gene can predispose to MODY3. It is associated with both micro and macrovascular complications of diabetes, especially cardiovascular complications. Associated with glucosuria. May respond well to sulfonylureas. However, more evidence is required to confer the association of this particular variant rs1421619915 with MODY3. |